✦ LIBER ✦

Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers

✍ Scribed by Ragai R. Mitry; Ruth De Bruyne; Alberto Quaglia; Robin D. Hughes; Anil Dhawan

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 46
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.21998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum proteomics and biomarker discovery

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

✍ Lauren N. Bell; Janice L. Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD), ranging from relatively benign simple steatosis to progressive nonalcoholic steatohepatitis (NASH) and fibrosis, is an increasingly common chronic liver disease. Liver biopsy is currently the only reliable tool for staging the subtypes of NAFLD; therefore, n

Diagnosis of fibrosis and cirrhosis usin

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

✍ Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; He 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries. Accurate noninvasive tests for liver injury are urgently needed. The aim of this study was to evaluate the accuracy of transient elastography for the diagnosis of fibrosis and cirrhosis in patien

Serum M30 levels: A potential biomarker

Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

✍ Yusuf Yilmaz; Engin Ulukaya; Enver Dolar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

We congratulate Fracanzani and colleagues 1 on their insightful article identifying factors associated with severe liver disease in patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels. First, the authors have convincingly demonstrated that normal alanine aminotr

In vivo assessment of liver cell apoptos

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

✍ Anna Wieckowska; Nizar N. Zein; Lisa M. Yerian; A. Rocio Lopez; Arthur J. McCull 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). Noninvasive methods are urgently needed. Increasing evidence suggests hepatocyte apoptosis is a key mediator of liver in

Noninvasive markers of fibrosis in nonal

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

✍ Indra Neil Guha; Julie Parkes; Paul Roderick; Dipanker Chattopadhyay; Richard Cr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

The detection of fibrosis within nonalcoholic fatty liver disease (NAFLD) is important for ascertaining prognosis and the stratification of patients for emerging therapeutic intervention. We validated the Original European Liver Fibrosis panel (OELF) and a simplified algorithm not containing age, th

Serum ferritin is an independent predict

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

✍ Kris V. Kowdley; Patricia Belt; Laura A. Wilson; Matthew M. Yeh; Brent A. Neusch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Serum ferritin (SF) levels are commonly elevated in patients with nonalcoholic fatty liver disease (NAFLD) because of systemic inflammation, increased iron stores, or both. The aim of this study was to examine the relationship between elevated SF and NAFLD severity. Demographic, clinical, histologic